Eric Lefkofskys Tempus Combine Efforts with Feist-Weiller Cancer Center to Take the Fight Cancer to the Next Level

Eric Lefkofsky broke the news that Tempus will combine efforts with Feist-Weiller Cancer Center recently. The two partners will embark on a research aimed at helping brain cancer patients with treatment options. Eric Lefkofsky is the Founder and CEO of Tempus, a company focused on collecting and analyzing molecular as well as clinical data.

Tempus leverages genomic testing to analyze RNA, DNA, as well as proteomic data. This is an effort to make physicians understand tumors at a molecular level to be able to tailor treatments which meets the specific needs of each individual patient. Tempus also works in large scale to organize results, clinical notes, radiology scans as well as pathology images in an effort to empower physicians to understand the clinical context of each case.

Tempus has large sources of both clinical and molecular data that is tailored to support the efforts of physicians to identify the most effective treatment options for their patients. The data also allows physicians to understand the molecular profiles of their patients as well as determine the most effective insights cultivated by machine-learning algorithms as well as advanced analytics. Eric Lefkofsky believes that artificial intelligence is helping in the figfht for prolonged and healthier lives of cancer patients.

Tempus is working with Maria-Magdalena Georgescu, M.D., M.D., Ph.D. directly toward the goals of both companies. Dr. Georgescu has been doing research and studying patients suffering from glioblastoma. Dr. Georgescu has also studied patients with metastatic brain disease, especially those who are not responding to conventional therapies. Glioblastoma is a deadly brain tumor today.

Tempus will guide clinical data structuring as well as genomic sequencing for the patients of Dr. Georgescu. It will also leverage machine learning as well as bioinformatics to analyze clinical data and find patterns that can inform how patients respond to therapy.

Eric Lefkofsky came in to fill the gap in the healthcare sector and came in to start Tempus to fulfill the need. He realized how important it is for physicians to get access to the data that could help in effective treatment of patients leveraging on the information of patients who came before them to learn. The company is now made up of competent bioinformaticians, engineers, scientists, biologists, physicians among others.